(University of North Carolina Health Care) The US Food and Drug Administration (FDA) approved ZULRESSO (brexanolone) injection today for the treatment of postpartum depression (PPD) after reviewing the results from three multicenter, randomized, double-blind, parallel-group, placebo-controlled trials in the US.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2TgAp5C
No comments:
Post a Comment